Cerity Partners’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Cerity Partners's EXEL Position: Q2 2026 in Review
Cerity Partners increased its Exelixis (EXEL) stake by 20% in Q2 2026, buying an estimated $3.08M and bringing the position to 377,130 shares worth $20.5M. The position accounts for 0.02% of the portfolio, ranked #481.
Cerity Partners first reported a position in EXEL in Q1 2024 and has held it in 10 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Cerity Partners held 377,130 shares of Exelixis worth $20.5M as of Q2 2026.
- Cerity Partners bought 63,185 Exelixis shares in Q2 2026, an estimated $3.08M.
- Exelixis made up 0.02% of Cerity Partners's portfolio in Q2 2026, its #481 holding.
- Cerity Partners first reported a position in Exelixis in Q1 2024 and has held it in 10 quarters since.
- 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.